Cronos Group reported a net revenue of $11.4 million, a gross loss of $1.5 million, and an operating loss of $41.2 million for Q3 2020. The company saw revenue growth primarily driven by the Canadian cannabis market, the Redwood acquisition, and the Israeli medical cannabis market.
Net revenue of $11.4 million in Q3 2020 increased by $5.6 million from Q3 2019.
Gross loss of $1.5 million in Q3 2020 decreased by $1.6 million from Q3 2019.
Reported operating loss of $41.2 million in Q3 2020 increased by $10.5 million from Q3 2019.
Kurt Schmidt appointed President and CEO; Mike Gorenstein appointed Executive Chairman
No specific forward guidance provided in the earnings report.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance